Skip to main content

Advertisement

SpringerLink
Log in

Should we resect peri-lesional hemosiderin deposits when performing lesionectomy in patients with cavernoma-related epilepsy (CRE)?

  • Short Review
  • Published:
Neurosurgical Review Aims and scope Submit manuscript

Abstract

In this review, the authors perform a database search and summarize and discuss all eligible studies that provide (subgroup) analysis of the postoperative seizure outcome of patients with cavernoma-related epilepsy undergoing sole lesionectomy or lesionectomy including the hemosiderin rim. Based on the currently available data, the authors conclude that if surgical treatment of cavernoma-related epilepsy is performed, the peri-lesional hemosiderin should be resected. However, cases of eloquent or multiple localization or widespread hemosiderin deposit in which a complete resection is challenging should undergo a specific preoperative work-up.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

  1. Batra S, Lin D, Recinos PF, Zhang J, Rigamonti D (2009) Cavernous malformations: natural history, diagnosis and treatment. Nat Rev Neurol 5:659–670. doi:10.1038/nrneurol.2009.177

    Article  PubMed  Google Scholar 

  2. Baumann CR, Schuknecht B, Lo Russo G, Cossu M, Citterio A, Andermann F, Siegel AM (2006) Seizure outcome after resection of cavernous malformations is better when surrounding hemosiderin-stained brain also is removed. Epilepsia 47:563–566. doi:10.1111/j.1528-1167.2006.00468.x

    Article  PubMed  Google Scholar 

  3. Cappabianca P, Alfieri A, Maiuri F, Mariniello G, Cirillo S, de Divitiis E (1997) Supratentorial cavernous malformations and epilepsy: seizure outcome after lesionectomy on a series of 35 patients. Clin Neurol Neurosurg 99:179–183

    Article  CAS  PubMed  Google Scholar 

  4. Chusid JG, Kopeloff LM (1962) Epileptogenic effects of pure metals implanted in motor cortex of monkeys. J Appl Physiol 17:697–700

    CAS  PubMed  Google Scholar 

  5. Dammann P, Wrede K, Jabbarli R, Neuschulte S, Menzler K, Zhu Y, Ozkan N, Muller O, Forsting M, Rosenow F, Sure U (2016) Outcome after conservative management or surgical treatment for new-onset epilepsy in cerebral cavernous malformation. J Neurosurg 1:1–9. doi:10.3171/2016.4.JNS1661

    Google Scholar 

  6. Engel J Jr (1993) Update on surgical treatment of the epilepsies. Summary of the Second International Palm Desert Conference on the Surgical Treatment of the Epilepsies (1992). Neurology 43:1612–1617

    Article  PubMed  Google Scholar 

  7. Englot DJ, Han SJ, Lawton MT, Chang EF (2011) Predictors of seizure freedom in the surgical treatment of supratentorial cavernous malformations. J Neurosurg 115:1169–1174. doi:10.3171/2011.7.JNS11536

    Article  PubMed  Google Scholar 

  8. Hammen T, Romstock J, Dorfler A, Kerling F, Buchfelder M, Stefan H (2007) Prediction of postoperative outcome with special respect to removal of hemosiderin fringe: a study in patients with cavernous haemangiomas associated with symptomatic epilepsy. Seizure 16:248–253. doi:10.1016/j.seizure.2007.01.001

    Article  CAS  PubMed  Google Scholar 

  9. Huang C, Chen MW, Si Y, Li JM, Zhou D (2013) Factors associated with epileptic seizure of cavernous malformations in the central nervous system in West China. Pakistan journal of medical sciences 29:1116–1121

    PubMed  PubMed Central  Google Scholar 

  10. Jin Y, Zhao C, Zhang S, Zhang X, Qiu Y, Jiang J (2014) Seizure outcome after surgical resection of supratentorial cavernous malformations plus hemosiderin rim in patients with short duration of epilepsy. Clin Neurol Neurosurg 119:59–63. doi:10.1016/j.clineuro.2014.01.013

    Article  PubMed  Google Scholar 

  11. Josephson CB, Leach JP, Duncan R, Roberts RC, Counsell CE, Al-Shahi Salman R (2011) Seizure risk from cavernous or arteriovenous malformations: prospective population-based study. Neurology 76:1548–1554. doi:10.1212/WNL.0b013e3182190f37

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. Kivelev J, Niemela M, Kivisaari R, Dashti R, Laakso A, Hernesniemi J (2009) Long-term outcome of patients with multiple cerebral cavernous malformations. Neurosurgery 65:450–455 . doi:10.1227/01.NEU.0000346269.59554.DBdiscussion 455

    Article  PubMed  Google Scholar 

  13. Kwon CS, Sheth SA, Walcott BP, Neal J, Eskandar EN, Ogilvy CS (2013) Long-term seizure outcomes following resection of supratentorial cavernous malformations. Clin Neurol Neurosurg 115:2377–2381. doi:10.1016/j.clineuro.2013.08.024

    Article  PubMed  Google Scholar 

  14. Luders HO, Najm I, Nair D, Widdess-Walsh P, Bingman W (2006) The epileptogenic zone: general principles. Epileptic disorders: international epilepsy journal with videotape 8(Suppl 2):S1–S9

    Google Scholar 

  15. Morrison L, Akers A (1993) Cerebral cavernous malformation, familial. In: Pagon RA, Adam MP, Ardinger HH et al. (eds) GeneReviews(R). Seattle (WA)

  16. Rocamora R, Mader I, Zentner J, Schulze-Bonhage A (2009) Epilepsy surgery in patients with multiple cerebral cavernous malformations. Seizure 18:241–245. doi:10.1016/j.seizure.2008.10.006

    Article  CAS  PubMed  Google Scholar 

  17. Rosenow F, Alonso-Vanegas MA, Baumgartner C, Blumcke I, Carreno M, Gizewski ER, Hamer HM, Knake S, Kahane P, Luders HO, Mathern GW, Menzler K, Miller J, Otsuki T, Ozkara C, Pitkanen A, Roper SN, Sakamoto AC, Sure U, Walker MC, Steinhoff BJ, Surgical Task Force CTSI (2013) Cavernoma-related epilepsy: review and recommendations for management—report of the Surgical Task Force of the ILAE Commission on Therapeutic Strategies. Epilepsia 54:2025–2035. doi:10.1111/epi.12402

    Article  PubMed  Google Scholar 

  18. Ruan D, Yu XB, Shrestha S, Wang L, Chen G (2015) The role of hemosiderin excision in seizure outcome in cerebral cavernous malformation surgery: a systematic review and meta-analysis. PLoS One 10:e0136619. doi:10.1371/journal.pone.0136619

    Article  PubMed  PubMed Central  Google Scholar 

  19. Sevy A, Gavaret M, Trebuchon A, Vaugier L, Wendling F, Carron R, Regis J, Chauvel P, Gonigal AM, Bartolomei F (2014) Beyond the lesion: the epileptogenic networks around cavernous angiomas. Epilepsy Res 108:701–708. doi:10.1016/j.eplepsyres.2014.02.018

    Article  PubMed  Google Scholar 

  20. Shan YZ, Fan XT, Meng L, An Y, Xu JK, Zhao GG (2015) Treatment and outcome of epileptogenic temporal cavernous malformations. Chin Med J 128:909–913. doi:10.4103/0366-6999.154289

    Article  PubMed  PubMed Central  Google Scholar 

  21. Sommer B, Grummich P, Coras R, Kasper BS, Blumcke I, Hamer HM, Stefan H, Buchfelder M, Roessler K (2013) Integration of functional neuronavigation and intraoperative MRI in surgery for drug-resistant extratemporal epilepsy close to eloquent brain areas. Neurosurg Focus 34:E4. doi:10.3171/2013.2.FOCUS12397

    Article  PubMed  Google Scholar 

  22. Sommer B, Kasper BS, Coras R, Blumcke I, Hamer HM, Buchfelder M, Roessler K (2013) Surgical management of epilepsy due to cerebral cavernomas using neuronavigation and intraoperative MR imaging. Neurol Res 35:1076–1083. doi:10.1179/016164113X13801151880551

    Article  PubMed  PubMed Central  Google Scholar 

  23. Stavrou I, Baumgartner C, Frischer JM, Trattnig S, Knosp E (2008) Long-term seizure control after resection of supratentorial cavernomas: a retrospective single-center study in 53 patients. Neurosurgery 63:888–896 . doi:10.1227/01.NEU.0000327881.72964.6Ediscussion 897

    Article  PubMed  Google Scholar 

  24. Steiger HJ, Markwalder TM, Reulen HJ (1987) Clinicopathological relations of cerebral cavernous angiomas: observations in eleven cases. Neurosurgery 21:879–884

    Article  CAS  PubMed  Google Scholar 

  25. Van Gompel JJ, Rubio J, Cascino GD, Worrell GA, Meyer FB (2009) Electrocorticography-guided resection of temporal cavernoma: is electrocorticography warranted and does it alter the surgical approach? J Neurosurg 110:1179–1185. doi:10.3171/2008.10.JNS08722

    Article  PubMed  PubMed Central  Google Scholar 

  26. von der Brelie C, Malter MP, Niehusmann P, Elger CE, von Lehe M, Schramm J (2013) Surgical management and long-term seizure outcome after epilepsy surgery for different types of epilepsy associated with cerebral cavernous malformations. Epilepsia 54:1699–1706. doi:10.1111/epi.12327

    Article  PubMed  Google Scholar 

  27. von der Brelie C, Schramm J (2011) Cerebral cavernous malformations and intractable epilepsy: the limited usefulness of current literature. Acta Neurochir 153:249–259. doi:10.1007/s00701-010-0915-z

    Article  PubMed  Google Scholar 

  28. von der Brelie C, von Lehe M, Raabe A, Niehusmann P, Urbach H, Mayer C, Elger CE, Malter MP (2014) Surgical resection can be successful in a large fraction of patients with drug-resistant epilepsy associated with multiple cerebral cavernous malformations. Neurosurgery 74:147–153 . doi:10.1227/NEU.0000000000000210discussion 153

    Article  PubMed  Google Scholar 

  29. Wang X, Tao Z, You C, Li Q, Liu Y (2013) Extended resection of hemosiderin fringe is better for seizure outcome: a study in patients with cavernous malformation associated with refractory epilepsy. Neurol India 61:288–292. doi:10.4103/0028-3886.115070

    Article  PubMed  Google Scholar 

  30. Wieser HG, Blume WT, Fish D, Goldensohn E, Hufnagel A, King D, Sperling MR, Luders H, Pedley TA, Commission on Neurosurgery of the International League Against E (2001) ILAE Commission Report. Proposal for a new classification of outcome with respect to epileptic seizures following epilepsy surgery. Epilepsia 42:282–286

    Article  CAS  PubMed  Google Scholar 

  31. Yeon JY, Kim JS, Choi SJ, Seo DW, Hong SB, Hong SC (2009) Supratentorial cavernous angiomas presenting with seizures: surgical outcomes in 60 consecutive patients. Seizure 18:14–20. doi:10.1016/j.seizure.2008.05.010

    Article  PubMed  Google Scholar 

  32. Zevgaridis D, van Velthoven V, Ebeling U, Reulen HJ (1996) Seizure control following surgery in supratentorial cavernous malformations: a retrospective study in 77 patients. Acta Neurochir 138:672–677

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Neurosurgery, University Hospital Essen, Hufelandstrasse 55, 45121, Essen, Germany

    P. Dammann & U. Sure

  2. Department of Neurosurgery, University Hospital Geneva, Geneva, Switzerland

    P. Dammann & C. Schaller

Authors
  1. P. Dammann
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. C. Schaller
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. U. Sure
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to P. Dammann.

Ethics declarations

Conflict of interest

The authors declare that they have no competing interests.

Funding

No funding was received for this work.

Ethical approval

Not applicable.

Informed consent

Not applicable.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Dammann, P., Schaller, C. & Sure, U. Should we resect peri-lesional hemosiderin deposits when performing lesionectomy in patients with cavernoma-related epilepsy (CRE)?. Neurosurg Rev 40, 39–43 (2017). https://doi.org/10.1007/s10143-016-0797-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10143-016-0797-5

Keywords

Search

Navigation